Duloxetine Lilly Ευρωπαϊκή Ένωση - Λιθουανικά - EMA (European Medicines Agency)

duloxetine lilly

eli lilly nederland b.v. - duloksetinas - neuralgia; diabetic neuropathies; depressive disorder, major - psychoanaleptics, - duloxetine lilly yra nurodyta suaugusiems:gydant didžiosios depresijos disordertreatment cukriniu diabetu periferinis neuropatinis paintreatment, generalizuoto nerimo disorderduloxetine lilly yra nurodyta suaugusieji.

Firdapse (previously Zenas) Ευρωπαϊκή Ένωση - Λιθουανικά - EMA (European Medicines Agency)

firdapse (previously zenas)

serb sa - amifampridinas - lambert-eaton miaestininis sindromas - kiti nervų sistemos vaistai - simptominis lambert-eaton myastheninio sindromo (lems) gydymas suaugusiesiems.

Yentreve Ευρωπαϊκή Ένωση - Λιθουανικά - EMA (European Medicines Agency)

yentreve

eli lilly nederland b.v. - duloksetino hidrochloridas - Šlapimo nelaikymas, stresas - psychoanaleptics, - yentreve skiriamas moterims vidutinio sunkumo ir sunkiam streso šlapimo nelaikymui (sui).

Prezista Ευρωπαϊκή Ένωση - Λιθουανικά - EMA (European Medicines Agency)

prezista

janssen-cilag international nv - darunaviras - Živ infekcijos - antivirusiniai vaistai sisteminiam naudojimui - prezista, co administered with low dose ritonavir is indicated in combination with other antiretroviral medicinal products for the treatment of human immunodeficiency virus (hiv 1) infection in adult and paediatric patients from the age of 3 years and at least 15 kg body weight. prezista, co administered with cobicistat is indicated in combination with other antiretroviral medicinal products for the treatment of human immunodeficiency virus (hiv 1) infection in adults and adolescents (aged 12 years and older, weighing at least 40 kg). in deciding to initiate treatment with prezista co administered with cobicistat or low dose ritonavir, careful consideration should be given to the treatment history of the individual patient and the patterns of mutations associated with different agents. genotypic or phenotypic testing (when available) and treatment history should guide the use of prezista. prezista, co administered with low dose ritonavir is indicated in combination with other antiretroviral medicinal products for the treatment of patients with human immunodeficiency virus (hiv 1) infection. prezista 75 mg, 150 mg, and 600 mg tablets may be used to provide suitable dose regimens:for the treatment of hiv 1 infection in antiretroviral treatment (art) experienced adult patients, including those that have been highly pre treated. for the treatment of hiv 1 infection in paediatric patients from the age of 3 years and at least 15 kg body weight. in deciding to initiate treatment with prezista co administered with low dose ritonavir, careful consideration should be given to the treatment history of the individual patient and the patterns of mutations associated with different agents. genotypic or phenotypic testing (when available) and treatment history should guide the use of prezista. prezista, co administered with low dose ritonavir is indicated in combination with other antiretroviral medicinal products for the treatment of patients with human immunodeficiency virus (hiv 1) infection. prezista, co administered with cobicistat is indicated in combination with other antiretroviral medicinal products for the treatment of human immunodeficiency virus (hiv 1) infection in adults and adolescents (aged 12 years and older, weighing at least 40 kg). prezista 400 mg and 800 mg tablets may be used to provide suitable dose regimens for the treatment of hiv 1 infection in adult and paediatric patients from the age of 3 years and at least 40 kg body weight who are:antiretroviral therapy (art) naïve. art experienced with no darunavir resistance associated mutations (drv rams) and who have plasma hiv 1 rna < 100,000 copies/ml and cd4+ cell count ≥ 100 cells x 106/l. in deciding to initiate treatment with prezista in such art experienced patients, genotypic testing should guide the use of prezista.

Nodetrip (previously Xeristar) Ευρωπαϊκή Ένωση - Λιθουανικά - EMA (European Medicines Agency)

nodetrip (previously xeristar)

esteve pharmaceuticals, s.a. - duloksetinas - anxiety disorders; depressive disorder, major; diabetic neuropathies - psychoanaleptics, - gydant didžiosios depresijos sutrikimas;gydymo cukriniu diabetu periferinis neuropatinis skausmas;gydant generalizuoto nerimo sutrikimas;xeristar yra nurodyta suaugusieji.

Citalopram Vitabalans Λιθουανία - Λιθουανικά - SMCA (Valstybinė vaistų kontrolės tarnyba)

citalopram vitabalans

vitabalans oy - citalopramas - plėvele dengtos tabletės - 20 mg; 40 mg - citalopram

Elontril Λιθουανία - Λιθουανικά - SMCA (Valstybinė vaistų kontrolės tarnyba)

elontril

glaxosmithkline trading services limited - bupropiono hidrochloridas - modifikuoto atpalaidavimo tabletės - 150 mg; 300 mg - bupropion

Escitalopram Actavis Λιθουανία - Λιθουανικά - SMCA (Valstybinė vaistų kontrolės tarnyba)

escitalopram actavis

teva b.v. - escitalopramas - plėvele dengtos tabletės - 20 mg; 15 mg; 10 mg; 5 mg - escitalopram

Escitalopram Teva Λιθουανία - Λιθουανικά - SMCA (Valstybinė vaistų kontrolės tarnyba)

escitalopram teva

teva pharma b.v. - escitalopramas - plėvele dengtos tabletės - 20 mg; 10 mg - escitalopram

Esprital Λιθουανία - Λιθουανικά - SMCA (Valstybinė vaistų kontrolės tarnyba)

esprital

zentiva k.s. - mirtazapinas - plėvele dengtos tabletės - 30 mg - mirtazapine